Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP is representing Bora Pharmaceuticals in its acquisition of Upsher-Smith Laboratories. Bora Pharmaceuticals Co., Ltd. announced the acquisition of Upsher-Smith Laboratories, Inc., a generics manufacturer...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised United Therapeutics Corporation on its acquisition of Miromatrix Medical Inc., assisted by Faegre Drinker Biddle & Reath LLP. Piper Sandler...
You must be a Standard 1 Year member to access this content.
